Standard
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. / Andersson, Charlotte; Lyngbæk, Stig; Nguyen, Cu Dinh; Nielsen, Mia; Gislason, Gunnar H; Køber, Lars; Torp-Pedersen, Christian.
I:
J A M A: The Journal of the American Medical Association, Bind 308, Nr. 9, 2012, s. 882-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Andersson, C, Lyngbæk, S, Nguyen, CD, Nielsen, M
, Gislason, GH, Køber, L & Torp-Pedersen, C 2012, '
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes',
J A M A: The Journal of the American Medical Association, bind 308, nr. 9, s. 882-9.
https://doi.org/10.1001/2012.jama.10779APA
Andersson, C., Lyngbæk, S., Nguyen, C. D., Nielsen, M.
, Gislason, G. H., Køber, L., & Torp-Pedersen, C. (2012).
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes.
J A M A: The Journal of the American Medical Association,
308(9), 882-9.
https://doi.org/10.1001/2012.jama.10779Vancouver
Andersson C, Lyngbæk S, Nguyen CD, Nielsen M
, Gislason GH, Køber L o.a.
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes.
J A M A: The Journal of the American Medical Association. 2012;308(9):882-9.
https://doi.org/10.1001/2012.jama.10779Author
Andersson, Charlotte ; Lyngbæk, Stig ; Nguyen, Cu Dinh ; Nielsen, Mia ; Gislason, Gunnar H ; Køber, Lars ; Torp-Pedersen, Christian. / Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. I: J A M A: The Journal of the American Medical Association. 2012 ; Bind 308, Nr. 9. s. 882-9.
Bibtex
@article{0ee1b200204448e8bbf7bd7356a7ef4d,
title = "Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes",
abstract = "Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.",
author = "Charlotte Andersson and Stig Lyngb{\ae}k and Nguyen, {Cu Dinh} and Mia Nielsen and Gislason, {Gunnar H} and Lars K{\o}ber and Christian Torp-Pedersen",
year = "2012",
doi = "10.1001/2012.jama.10779",
language = "English",
volume = "308",
pages = "882--9",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "9",
}
RIS
TY - JOUR
T1 - Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes
AU - Andersson, Charlotte
AU - Lyngbæk, Stig
AU - Nguyen, Cu Dinh
AU - Nielsen, Mia
AU - Gislason, Gunnar H
AU - Køber, Lars
AU - Torp-Pedersen, Christian
PY - 2012
Y1 - 2012
N2 - Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.
AB - Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.
U2 - 10.1001/2012.jama.10779
DO - 10.1001/2012.jama.10779
M3 - Journal article
C2 - 22948698
VL - 308
SP - 882
EP - 889
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 9
ER -
